Roberto Mignone is Director at TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA). They have made 11 open-market trades across 5 companies since 2007, most recently 2026-09-21.
CIK 0001258394
5 open-market purchases totalling $26.5M since 2007, against 6 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| AVAN | 1,000,000 | $10.0M |
| TEVA | 119,807 | $5.0M |
| GH | 10,274 | $1.6M |
| ORCH | 3,962,179 | — |
| TRMS | 2,510,081 | — |
| TROV | 2,850,587 | — |
| Total | $16.6M |
Shares reported on the most recent Form 4, priced at the 2026-09-22 close. 3 holdings could not be priced and are excluded from the total.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| TEVA | SELL | 2026-09-18 | 2026-09-22 | $39.06 | $14.4M | -0.5% | — | — |
| TEVA | SELL | 2025-12-16 | 2025-12-18 | $30.24 | $2.3M | +3.7% | +4.2% | -1.6% |
| TEVA | SELL | 2025-11-26 | 2025-12-01 | $26.03 | $1.3M | +11.8% | +15.6% | +25.1% |
| TEVA | SELL | 2025-11-06 | 2025-11-10 | $24.11 | $4.8M | -0.4% | +22.2% | +41.4% |
| TEVA | SELL | 2024-12-20 | 2024-12-26 | $22.01 | $6.3M | -4.9% | -3.6% | -30.5% |
| TEVA | SELL | 2024-06-18 | 2024-06-21 | $17.03 | $8.8M | -0.1% | +0.9% | +5.5% |
| AVAN | BUY | 2020-10-01 | 2020-10-05 | $10.00 | $10.0M | +0.7% | -1.0% | +3.7% |
| TEVA | BUY | 2018-05-09 | 2018-05-11 | $19.25 | $14.4M | +6.9% | +17.2% | +12.8% |
| TROV | BUY | 2015-02-25 | 2015-02-27 | $5.36 | $1.4M | N/A | N/A | N/A |
| ORCH | BUY | 2008-12-12 | 2008-12-16 | $0.65 | $595K | N/A | N/A | N/A |
| TRMS | BUY | 2007-08-21 | 2007-08-23 | $7.00 | $71K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.